Total Payments
$62,874
2024 Payments
$26,839
Companies
28
Transactions
386
Medicare Patients
538
Medicare Billing
$46,936
Payment Breakdown by Category
Other$46,110 (73.3%)
Food & Beverage$8,740 (13.9%)
Travel$7,093 (11.3%)
Consulting$790.00 (1.3%)
Education$141.61 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,110 | 42 | 73.3% |
| Food and Beverage | $8,740 | 307 | 13.9% |
| Travel and Lodging | $7,093 | 31 | 11.3% |
| Consulting Fee | $790.00 | 2 | 1.3% |
| Education | $141.61 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $24,290 | 118 | $0 (2024) |
| Gilead Sciences, Inc. | $22,590 | 71 | $0 (2024) |
| Madrigal Pharmaceuticals | $7,103 | 16 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $5,016 | 17 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $909.97 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $646.31 | 29 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $595.72 | 23 | $0 (2024) |
| Celgene Corporation | $304.33 | 12 | $0 (2024) |
| Lilly USA, LLC | $176.18 | 7 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $162.71 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,839 | 155 | Gilead Sciences, Inc. ($11,664) |
| 2023 | $13,973 | 112 | Gilead Sciences, Inc. ($6,397) |
| 2022 | $9,189 | 76 | ABBVIE INC. ($8,499) |
| 2021 | $12,874 | 43 | AbbVie Inc. ($8,143) |
All Payment Transactions
386 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: Gastroenterology | ||||||
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: Gastroenterology | ||||||
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $0.35 | General |
| Category: Gastroenterology | ||||||
| 12/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $39.74 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.33 | General |
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $139.28 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: VIROLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $57.63 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $124.82 | General |
| Category: HBV | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: HCV | ||||||
| 11/05/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $55.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Travel and Lodging | In-kind items and services | $102.50 | General |
| Category: HCV | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,485.00 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 170 | 186 | $56,976 | $14,574 |
| 2022 | 5 | 289 | 314 | $97,625 | $23,717 |
| 2021 | 2 | 79 | 79 | $28,210 | $8,644 |
Total Patients
538
Total Services
579
Medicare Billing
$46,936
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 95 | $26,898 | $8,124 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $15,404 | $3,690 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 38 | $7,549 | $2,332 | 30.9% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 19 | 19 | $7,125 | $427.86 | 6.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 126 | $34,020 | $10,382 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 75 | 75 | $32,250 | $7,758 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 47 | $8,930 | $2,715 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $9,300 | $2,098 | 22.6% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 34 | 35 | $13,125 | $764.01 | 5.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $18,490 | $5,190 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 36 | $9,720 | $3,454 | 35.5% |
About Lauri Welch, NP
Lauri Welch, NP is a Nurse Practitioner healthcare provider based in North Chelmsford, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972625788.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lauri Welch, NP has received a total of $62,874 in payments from pharmaceutical and medical device companies, with $26,839 received in 2024. These payments were reported across 386 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($46,110).
As a Medicare-enrolled provider, Welch has provided services to 538 Medicare beneficiaries, totaling 579 services with total Medicare billing of $46,936. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location North Chelmsford, MA
- Active Since 04/04/2007
- Last Updated 12/11/2007
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1972625788
Products in Payments
- Epclusa (Drug) $17,394
- CREON (Drug) $10,201
- REZDIFFRA (Drug) $7,005
- LINZESS (Drug) $6,134
- VOQUEZNA (Drug) $5,016
- MAVYRET (Drug) $3,149
- XIFAXAN (Drug) $705.45
- ENTYVIO (Biological) $449.86
- STELARA (Biological) $325.72
- ZEPOSIA (Drug) $304.33
- SKYRIZI (Biological) $220.04
- RINVOQ (Biological) $216.19
- TRULANCE (Drug) $204.52
- TREMFYA (Drug) $178.10
- OMVOH (Drug) $176.18
- Linzess (Drug) $162.71
- REMICADE (Biological) $142.49
- DUPIXENT (Biological) $141.02
- Vemlidy (Drug) $124.82
- XELJANZ (Drug) $123.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in North Chelmsford
Kristen Mcfadden, Np, NP
Nurse Practitioner — Payments: $4,794
Nurse Practitioner $4,794
Prarthana Kumari, Fnp, FNP
Nurse Practitioner — Payments: $3,094
Nurse Practitioner $3,094
Heather Lacharite, A-Gnp-C, A-GNP-C
Nurse Practitioner — Payments: $1,480
Nurse Practitioner $1,480
June Stott, Arnp, ARNP
Nurse Practitioner — Payments: $331.23
Nurse Practitioner $331.23
Marva Murphy, Aprn, APRN
Nurse Practitioner
Nurse Practitioner